https://lindenlakelabs.com/antibody-drug-conjugate-cdmo-xcellon-partners-with-invenra/ 2026-04-12T02:00:17+00:00 https://lindenlakelabs.com/intocell-and-xcellon-biologics-partner-to-expand-access-to-next-generation-adc-technologies/ 2026-04-12T02:00:17+00:00 https://lindenlakelabs.com/xcellon-biologics-launches-xcellerate-program-to-support-early-stage-biotech-innovation/ 2026-04-12T02:00:17+00:00 https://lindenlakelabs.com/xcellon-biologics-modular-fc-glycan-conjugation-unlocking-next-generation-antibody-therapeutics/ 2026-04-12T02:00:18+00:00 https://lindenlakelabs.com/from-global-pharma-to-marylands-next-gen-cdmo-yuk-chun-chius-vision-for-xcellon-biologics/ 2026-04-12T02:00:18+00:00 https://lindenlakelabs.com/tedco-equitech-growth-fund-awarded-xcellon-biologics/ 2026-04-12T02:00:18+00:00 https://lindenlakelabs.com/crossbridge-bio-enters-an-agreement-to-be-acquired-by-eli-lilly-to-advance-next-generation-dual-payload-antibody-drug-conjugates/ 2026-04-14T14:21:08+00:00